Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Respiratory Medicine

P1.09-28 Clinical Utility of Rapid Immunohistochemistry for Differentiation of Solitary Pulmonary Adenocarcinomas

Journal of Thoracic Oncology

English

Targeted Nanoconjugate Co-Delivering siRNA and Tyrosine Kinase Inhibitor to Kras Mutant NSCLC Reveals Gab1 Assisted Survival Pathway Post Oncogene Knockdown

Journal of Thoracic Oncology

English

Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient With MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR Tyrosine Kinase Inhibition

Journal of Thoracic Oncology

English

OA03.02 Nationwide Comparative Study of PD-L1 IHC Assays on Lung Cancer: Initial Report of LC-SCRUM-IBIS Project

Journal of Thoracic Oncology

English

P1.01-10 Stage III Non-Small Cell Lung Cancer Clinical Outcomes With Surgical Resection After Definitive Neoadjuvant Chemoradiotherapy

Journal of Thoracic Oncology

English

P1.03-20 the Novel SFN Inhibitors Aprepitant and Ticagrelor Exert Anti-Tumor Effects Through Blocking of Oncoprotein Ubiquitination

Journal of Thoracic Oncology

English

P1.12-14 Survival of Patients With Small-Cell Lung Cancer Undergoing Surgical Resection

Journal of Thoracic Oncology

English

P2.16-45 Should Patients With Stage IB Non-Small Cell Lung Cancer Receive Adjuvant Chemotherapy?

Journal of Thoracic Oncology

English

S157 Prevalence of Asthma Related to Employment in the UK

English

P2.03-13 SWATH MS Analysis of Serine Hydrolase Activity in Human Lung Adenocarcinoma for Biomarker Discovery

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Respiratory Medicine

P1.09-28 Clinical Utility of Rapid Immunohistochemistry for Differentiation of Solitary Pulmonary Adenocarcinomas

Targeted Nanoconjugate Co-Delivering siRNA and Tyrosine Kinase Inhibitor to Kras Mutant NSCLC Reveals Gab1 Assisted Survival Pathway Post Oncogene Knockdown

Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient With MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR Tyrosine Kinase Inhibition

OA03.02 Nationwide Comparative Study of PD-L1 IHC Assays on Lung Cancer: Initial Report of LC-SCRUM-IBIS Project

P1.01-10 Stage III Non-Small Cell Lung Cancer Clinical Outcomes With Surgical Resection After Definitive Neoadjuvant Chemoradiotherapy

P1.03-20 the Novel SFN Inhibitors Aprepitant and Ticagrelor Exert Anti-Tumor Effects Through Blocking of Oncoprotein Ubiquitination

P1.12-14 Survival of Patients With Small-Cell Lung Cancer Undergoing Surgical Resection

P2.16-45 Should Patients With Stage IB Non-Small Cell Lung Cancer Receive Adjuvant Chemotherapy?

S157 Prevalence of Asthma Related to Employment in the UK

P2.03-13 SWATH MS Analysis of Serine Hydrolase Activity in Human Lung Adenocarcinoma for Biomarker Discovery